DUBLIN--(BUSINESS WIRE)--The "High Potency APIs/HPAPI Market by Type (Innovative, Generic), Synthesis (Synthetic, Biotech, moAB, Vaccines, Recombinant Proteins), Manufacturer (Captive and Merchant), Therapy (Oncology, Glaucoma, Hormonal Imbalance) - Global Forecasts to 2023" report has been added to ResearchAndMarkets.com's offering.
The global HPAPIs market is expected to reach USD 26.84 billion by 2023 from USD 17.72 billion in 2018, at a CAGR 8.7%.
The growth in this market is driven by factors such as increasing demand for oncology drugs, growing demand for antibody-drug conjugates, increasing focus of leading pharmaceutical companies on HPAPIs, advancements in HPAPI manufacturing technologies, and growing focus on precision medicine.
On the other hand, the requirement of large investments, discrepancies in HPAPI banding systems, uncertainties associated with products, and the high risk of cross-contamination are expected to limit market growth in the coming years. The need for appropriate process designs and the constant evolution of industry standards and technologies are also expected to challenge market growth to a certain extent.
Based on type, the HPAPIs market is segmented into innovative and generic APIs. The generic HPAPIs segment is expected to register the highest growth rate during the forecast period. The impending patent cliff, increasing healthcare costs, and government initiatives to encourage the adoption of generics are the major factors driving the growth of this market segment.
On the basis of type of manufacturer, the HPAPIs market is segmented into captive HPAPI and merchant HPAPI manufacturers. In 2018, the captive HPAPI manufacturers segment is expected to account for the largest share of the market. The large share of this segment is attributed to the preference of innovative companies to maintain in-house manufacturing facilities for economic benefits.
Key Topics Covered
1 HPAPI Market: Introduction
2 HPAPI Market: Research Methodology
3 HPAPI Market: Executive Summary
4 HPAPI Market: Premium Insights
5 HPAPI Market: Overview
6 High-Potency Active Pharmaceutical Ingredients Classification and Overview
7 HPAPI Market, By Type
8 HPAPI Market, By Type of Synthesis
9 HPAPI Market, By Type of Manufacturer
10 HPAPI Market, By Therapeutic Application
11 HPAPI Market, By Region
12 Competitive Landscape
13 Company Profiles
- Abbvie
- Bayer
- Boehringer Ingelheim
- Bristol-Myers Squibb
- ELI Lilly and Company
- F. Hoffmann-La Roche
- Merck
- Mylan
- Novartis International AG
- Pfizer
- Sanofi
- Teva Pharmaceutical Industries
For more information about this report visit https://www.researchandmarkets.com/research/vgg8qq/high_potency?w=4
